-
Something wrong with this record ?
HPV, protein p16 and squamous cell carcinoma of the oral cavity
J. Blahak, J. Zelinka, J. Gumulec, C. Machacek, Z. Danek, O. Bulik
Language English Country Czech Republic
Document type Journal Article
NLK
Directory of Open Access Journals
from 2001
Free Medical Journals
from 1998
Medline Complete (EBSCOhost)
from 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
from 2001
PubMed
31219104
DOI
10.5507/bp.2019.026
Knihovny.cz E-resources
- MeSH
- Papillomavirus Infections diagnosis physiopathology MeSH
- Cyclin-Dependent Kinase Inhibitor p16 metabolism MeSH
- Middle Aged MeSH
- Humans MeSH
- Survival Rate MeSH
- Mouth Neoplasms diagnosis physiopathology MeSH
- Prognosis MeSH
- Aged MeSH
- Carcinoma, Squamous Cell diagnosis physiopathology MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
BACKGROUND: Squamous cell carcinoma of the oral cavity is generally caused by the long-term impact of known risk factors, e.g. tobacco and alcohol, along with chronic traumatisation. A number of studies now implicate HPV infection in head and neck tumour carcinogenesis but the exact role of HPV infection in the oral cavity remains unclear. METHODS: In this study, we evaluated 78 patients with oral squamous cell carcinoma (OSCC) for the expression of protein p16 in the context of HPV positivity and its influence on the overall survival rate, disease location, staging and grading. RESULTS: Regarding the tumour location, no significant difference was found between HPV-positive and HPV-negative patients, nor between p16-positive and p16-negative patients. There was also no trend in terms of HPV status and stage, and differentiation of carcinoma. There was no effect on HPV-positive patients relative to the time to progression (P=0.84) and overall survival rate (P=0.78). P16 positivity was not found to have an effect on the overall survival rate of patients (P=0.41) and there was no correlation between p16 positivity relative to the time to progression (P=0.66). CONCLUSIONS: In summary, the data suggest that there is no effect of HPV status on the prognosis of OSCC patients compared to other HNSCC locations.
References provided by Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21021190
- 003
- CZ-PrNML
- 005
- 20210908164856.0
- 007
- ta
- 008
- 210806s2020 xr ad f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2019.026 $2 doi
- 035 __
- $a (PubMed)31219104
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Blahák, Jiří, $d 1986- $7 xx0195644 $u Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Masaryk University, Brno and University Hospital Brno, Brno, Czech Republic
- 245 10
- $a HPV, protein p16 and squamous cell carcinoma of the oral cavity / $c J. Blahak, J. Zelinka, J. Gumulec, C. Machacek, Z. Danek, O. Bulik
- 504 __
- $a Literatura
- 520 9_
- $a BACKGROUND: Squamous cell carcinoma of the oral cavity is generally caused by the long-term impact of known risk factors, e.g. tobacco and alcohol, along with chronic traumatisation. A number of studies now implicate HPV infection in head and neck tumour carcinogenesis but the exact role of HPV infection in the oral cavity remains unclear. METHODS: In this study, we evaluated 78 patients with oral squamous cell carcinoma (OSCC) for the expression of protein p16 in the context of HPV positivity and its influence on the overall survival rate, disease location, staging and grading. RESULTS: Regarding the tumour location, no significant difference was found between HPV-positive and HPV-negative patients, nor between p16-positive and p16-negative patients. There was also no trend in terms of HPV status and stage, and differentiation of carcinoma. There was no effect on HPV-positive patients relative to the time to progression (P=0.84) and overall survival rate (P=0.78). P16 positivity was not found to have an effect on the overall survival rate of patients (P=0.41) and there was no correlation between p16 positivity relative to the time to progression (P=0.66). CONCLUSIONS: In summary, the data suggest that there is no effect of HPV status on the prognosis of OSCC patients compared to other HNSCC locations.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a spinocelulární karcinom $x diagnóza $x patofyziologie $7 D002294
- 650 _2
- $a inhibitor p16 cyklin-dependentní kinasy $x metabolismus $7 D019941
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a nádory úst $x diagnóza $x patofyziologie $7 D009062
- 650 _2
- $a infekce papilomavirem $x diagnóza $x patofyziologie $7 D030361
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a míra přežití $7 D015996
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Zelinka, Jiří $7 xx0231273 $u Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Masaryk University, Brno and University Hospital Brno, Brno, Czech Republic
- 700 1_
- $a Gumulec, Jaromír, $d 1963- $7 xx0054104 $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Macháček, Ctirad $7 xx0154019 $u Department of Pathology, Faculty of Medicine, Masaryk University, Brno and University Hospital Brno, Brno, Czech Republic
- 700 1_
- $a Daněk, Zdeněk $7 xx0191609 $u Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Masaryk University, Brno and University Hospital Brno, Brno, Czech Republic
- 700 1_
- $a Bulik, Oliver $7 xx0107917 $u Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Masaryk University, Brno and University Hospital Brno, Brno, Czech Republic
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1213-8118 $g Roč. 164, č. 3 (2020), s. 292-299
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31219104 $y Pubmed
- 910 __
- $a ABA008 $b A 1502 $c 958 $y p $z 0
- 990 __
- $a 20210806 $b ABA008
- 991 __
- $a 20210903151723 $b ABA008
- 999 __
- $a ok $b bmc $g 1694797 $s 1141643
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 164 $c 3 $d 292-299 $e 20190617 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK118 $a Pubmed-20210806